000 | 02000 a2200541 4500 | ||
---|---|---|---|
005 | 20250515173033.0 | ||
264 | 0 | _c20091105 | |
008 | 200911s 0 0 eng d | ||
022 | _a1476-5586 | ||
024 | 7 |
_a10.1593/neo.09254 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWitney, Timothy H | |
245 | 0 | 0 |
_aA comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _cJun 2009 |
||
300 |
_a574-82, 1 p following 582 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCarbon Isotopes |
650 | 0 | 4 | _aCarbon Radioisotopes |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aEtoposide _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xpharmacokinetics |
650 | 0 | 4 |
_aGlucose Transporter Type 1 _xmetabolism |
650 | 0 | 4 |
_aGlucose Transporter Type 3 _xmetabolism |
650 | 0 | 4 |
_aLactates _xmetabolism |
650 | 0 | 4 |
_aLymphoma _xdrug therapy |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 |
_aPyruvates _xmetabolism |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aKettunen, Mikko I | |
700 | 1 | _aDay, Samuel E | |
700 | 1 | _aHu, De-en | |
700 | 1 | _aNeves, Andre A | |
700 | 1 | _aGallagher, Ferdia A | |
700 | 1 | _aFulton, Sandra M | |
700 | 1 | _aBrindle, Kevin M | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 11 _gno. 6 _gp. 574-82, 1 p following 582 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.09254 _zAvailable from publisher's website |
999 |
_c18909062 _d18909062 |